Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Department of Biostatistics, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Bone Marrow Transplant. 2021 Jan;56(1):175-184. doi: 10.1038/s41409-020-00998-w. Epub 2020 Jul 14.
New diagnostic criteria and severity grading for sinusoidal obstructive syndrome (SOS) among pediatric and adolescent young adult (AYA) patients have been recently endorsed by international consensus. The extent to which these have been adopted in the US remains unclear. We sought to assess the potential impact via retrospective application of these criteria among patients treated at a large academic center in the United States. This is a single center retrospective study of pediatric-AYA patients who underwent hematopoietic cell transplantation (HCT) between July 2009 and 2019. The incidence of SOS was assessed using historic Baltimore and Seattle diagnostic criteria and compared with more recent guidelines (pEBMT) as proposed by the Paediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. Among 226 patients, application of the pEBMT diagnostic criteria was associated with a higher incidence (15.9%) and earlier time to diagnosis of SOS (by 2.5-3 days) compared with the modified Seattle (12.3%), and Baltimore (6.6%) criteria, respectively. The pEBMT criteria were sensitive and highly specific. Refractory thrombocytopenia was present in 75% of patients at diagnosis. Approximately 61% of patients with SOS were anicteric at diagnosis, though the majority (94.4%) developed hyperbilirubinemia as SOS progressed over a median time of 4 (1-57) days. Application of pEBMT criteria may have resulted in earlier indication for definitive treatment by 3 days. Timely diagnosis and administration of definitive treatment of SOS has been associated with improved outcomes. Prospective studies may better characterize the risk factors and natural course of SOS using pEBMT criteria.
最近,国际共识认可了小儿和青少年成年(AYA)患者的窦状阻塞综合征(SOS)新的诊断标准和严重程度分级。这些标准在美国的采用程度尚不清楚。我们试图通过在美国一家大型学术中心回顾性应用这些标准来评估其潜在影响。这是一项对 2009 年 7 月至 2019 年间接受造血细胞移植(HCT)的小儿-AYA 患者进行的单中心回顾性研究。使用历史上的巴尔的摩和西雅图诊断标准评估 SOS 的发生率,并与最近的指南(pEBMT)进行比较,该指南由欧洲血液和骨髓移植学会儿科疾病工作组提出。在 226 名患者中,与改良后的西雅图(12.3%)和巴尔的摩(6.6%)标准相比,应用 pEBMT 诊断标准与更高的 SOS 发生率(15.9%)和更早的诊断时间(提前 2.5-3 天)相关。pEBMT 标准具有敏感性和高度特异性。诊断时,75%的患者存在难治性血小板减少症。约 61%的 SOS 患者在诊断时无黄疸,但大多数(94.4%)患者在中位时间为 4(1-57)天内随着 SOS 的进展会出现高胆红素血症。应用 pEBMT 标准可能会使明确治疗的指示提前 3 天。及时诊断和给予 SOS 的明确治疗与改善预后相关。前瞻性研究可能会更好地使用 pEBMT 标准来描述 SOS 的危险因素和自然病程。